View the latest Cara Therapeutics Inc. (CARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Cara Therapeutics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Cara Therapeutics, Inc. - CARA STOCK NEWS Welcome to our dedicated page for Cara Therapeutics news (Ticker: CARA), a resource for investors and traders. Stay up-to-date on Cara Therapeutics, Inc. Common Stock (CARA) news with the latest updates, breaking headlines, news articles, and more from around the web. View live Cara Therapeutics, Inc. chart to track its stock's price action. Find market predictions, CARA financials and market news.
CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Adicet Bio Inc. $ ACET % ; Outlook Therapeutics Inc. $ OTLK % ; Karyopharm Therapeutics Inc. $ KPTI % ; Clearside Biomedical Inc. $ Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates. Cara (CARA) delivered earnings and revenue surprises of % and %, respectively. Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients. Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary My News · RSS. CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to. Get Cara Therapeutics Inc (CARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Cara Therapeutics Stock Smart Score · Cara Therapeutics News · Bulls Say, Bears Say · Company Description · CARA Earnings Call · CARA Stock 12 Month Forecast. Cara Therapeutics (CARA) News Today Why Is Cara Therapeutics (CARA) Stock Down 27% Today? Being the Marquette women's basketball coach means a lot to Cara. Why Cara Therapeutics Stock Is Crashing Today The company reported disappointing results from a phase 2 study. Why Cara Therapeutics Stock Is Soaring Higher. Stock analysis for Cara Therapeutics Inc (CARA:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company.
Cara Therapeutics (CARA) reported Q2 earnings per share (EPS) of -$, missing estimates of -$ by %. In the same quarter last year, Cara. Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a treatment for pain in. Common Stock (CARA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. CARA Related stocks ; Cara Therapeutics ; AMGN, , +% ; Amgen Inc ; VRTX, , +%. The 29 analysts offering price forecasts for Cara Therapeutics have a median target of , with a high estimate of and a low estimate of CARA News · Cara Therapeutics CEO sells over $1, in stock · Cara Therapeutics receives Nasdaq compliance extension · Cara Therapeutics, Inc. · Metric Deep Dive. In the current month, CARA has received 5 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. CARA average Analyst price target in the past 3 months is $ What's Going On With Cara Therapeutics Stock? Cara Therapeutics shares are trading higher by 15% during Thursday's session. The company earlier announced it. Latest News · Cara Therapeutics Announces Exploration of Strategic Alternatives. July 11, · Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study.
Research Cara Therapeutics' (Nasdaq:CARA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Cara Therapeutics reports first quarter financial results. Topline efficacy and safety results from KOURAGE 1 Part A portion of notalgia paresthetica (NP). See charts, data and financials for Cara Therapeutics Inc CARA. Cara Therapeutic News & Analysis · Cara Therapeutics CEO sells over $1, in stock · Cara Therapeutics receives Nasdaq compliance extension · Maplebear Inc (CART). Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CARA will report earnings.
CARA - Cara Therapeutics, Inc. (NasdaqCM) - Share Price and News. Cara Therapeutics (CARA) - Develops new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors. · Cara Therapeutics Meets. Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in. The Cara Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Explore the latest news, in-depth analysis, performance evaluation, and Q&A for Cara Therapeutics Inc (CARA) stock. Gain valuable insights from earnings.
Best Place For Index Funds | Price Of Gold Over Last 50 Years